Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea
· Delayed Price · Currency is KRW 6,030.00
-50.00 (-0.82%)
At close: Apr 28, 2026
Sinsin Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 9,292 | 4,888 | 4,680 | 4,415 | -1,476 | Upgrade
|
| Depreciation & Amortization | 4,152 | 4,260 | 3,937 | 3,758 | 3,672 | Upgrade
|
| Loss (Gain) From Sale of Assets | -36.35 | -7 | 0 | -38.55 | -0.73 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 18.16 | Upgrade
|
| Loss (Gain) From Sale of Investments | -138.96 | 323.41 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 6.23 | 143.72 | -30.85 | -159.25 | 1.26 | Upgrade
|
| Other Operating Activities | 3,294 | 1,995 | 2,366 | 1,531 | -344.75 | Upgrade
|
| Change in Accounts Receivable | -2,202 | -2,597 | -2,201 | -2,373 | -659.54 | Upgrade
|
| Change in Inventory | -5,424 | -2,302 | -3,022 | -5,062 | 1,316 | Upgrade
|
| Change in Accounts Payable | -1,465 | 195.72 | 241.53 | 2,063 | -2,165 | Upgrade
|
| Change in Other Net Operating Assets | 1,106 | -956.49 | -2,042 | 1,327 | -337.92 | Upgrade
|
| Operating Cash Flow | 8,584 | 5,943 | 3,930 | 5,461 | 23.18 | Upgrade
|
| Operating Cash Flow Growth | 44.42% | 51.23% | -28.03% | 23453.48% | -98.76% | Upgrade
|
| Capital Expenditures | -1,612 | -1,505 | -5,011 | -907.13 | -2,682 | Upgrade
|
| Sale of Property, Plant & Equipment | 36.7 | 7 | - | 43.64 | 0.79 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -10 | -16.11 | -94.65 | - | Upgrade
|
| Investment in Securities | -126.39 | -4,004 | -1,004 | -176.61 | -3.41 | Upgrade
|
| Other Investing Activities | -603.38 | -46 | -20 | -10 | 33 | Upgrade
|
| Investing Cash Flow | -2,305 | -5,557 | -6,051 | -1,145 | -2,652 | Upgrade
|
| Short-Term Debt Issued | 38,847 | 39,888 | 25,306 | 18,349 | 20,224 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | 3,000 | Upgrade
|
| Total Debt Issued | 38,847 | 39,888 | 25,306 | 18,349 | 23,224 | Upgrade
|
| Short-Term Debt Repaid | -39,165 | -35,397 | -20,958 | -19,275 | -17,421 | Upgrade
|
| Long-Term Debt Repaid | -1,685 | -3,790 | -3,434 | -1,899 | -4,914 | Upgrade
|
| Total Debt Repaid | -40,850 | -39,187 | -24,392 | -21,174 | -22,335 | Upgrade
|
| Net Debt Issued (Repaid) | -2,003 | 701.82 | 914.06 | -2,825 | 889.86 | Upgrade
|
| Dividends Paid | -910.23 | -910.23 | -758.53 | - | - | Upgrade
|
| Other Financing Activities | 15 | - | 70 | - | 35 | Upgrade
|
| Financing Cash Flow | -2,898 | -208.41 | 225.54 | -2,825 | 924.86 | Upgrade
|
| Foreign Exchange Rate Adjustments | -43.12 | 15.79 | 1.89 | -50.12 | -0.96 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | -0 | -0 | 0 | -0 | - | Upgrade
|
| Net Cash Flow | 3,337 | 193.4 | -1,894 | 1,441 | -1,705 | Upgrade
|
| Free Cash Flow | 6,971 | 4,439 | -1,081 | 4,553 | -2,659 | Upgrade
|
| Free Cash Flow Growth | 57.05% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 6.13% | 4.17% | -1.05% | 4.95% | -3.59% | Upgrade
|
| Free Cash Flow Per Share | 459.90 | 292.38 | -71.27 | 300.15 | -175.28 | Upgrade
|
| Cash Interest Paid | 1,631 | 1,956 | 1,987 | 1,406 | 948.55 | Upgrade
|
| Cash Income Tax Paid | 317.41 | 182.18 | -747.52 | -396.26 | 1,650 | Upgrade
|
| Levered Free Cash Flow | 4,170 | 1,950 | -3,157 | 3,362 | -2,642 | Upgrade
|
| Unlevered Free Cash Flow | 5,193 | 3,175 | -1,946 | 4,288 | -2,040 | Upgrade
|
| Change in Working Capital | -7,986 | -5,660 | -7,023 | -4,045 | -1,846 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.